Liposome as a Potential Drug Delivery System in Addressing Skin Diseases: A Review

IF 0.3 Q4 PHARMACOLOGY & PHARMACY
Shivam Malhotra, Shammy Jindal, Rajni Bala, R. Madaan
{"title":"Liposome as a Potential Drug Delivery System in Addressing Skin Diseases: A Review","authors":"Shivam Malhotra, Shammy Jindal, Rajni Bala, R. Madaan","doi":"10.2174/0115748855297829240227072642","DOIUrl":null,"url":null,"abstract":"\n\nIt was asserted that the manufacturing of liposomes, which was first disclosed in 1961,\nwas a useful technology for drug encapsulation. Furthermore, there are several cosmetic items on the\nmarket now that include liposomes. The liposomes are novel drug carrier systems due to their similarity\nin lipid composition with the epidermal membrane. As a result, they penetrate the epidermis to\na greater extent, showing enhanced skin absorption and increased effectiveness of the encapsulated\ndrug molecule.\nThis review briefly addresses the skin's anatomy, skin conditions, and the topical delivery of drugs\nfor the treatment of skin diseases with emphasis on psoriasis by utilizing liposomes and other vesicular\ndrug delivery systems along with challenges and opportunities in the treatment of skin diseases.\nWhen compared to alternative distribution methods, their resemblance to biological membranes enables\nentry into the epidermal barrier. Liposomes are good at penetrating the skin more deeply and\nreducing therapeutic side effects, which offers hope for the successful treatment of skin problems.\nApplying liposomes topically has several benefits, including better skin bioavailability and targeting,\nincreased skin hydration by surface adhesiveness, protection of skin structure from external stress,\nand prolonged dermal release. Further, they have got potential to target the encapsulated drug molecule\ninto pilosebaceous structure, making them an ideal candidate for the treatment of hair follicles\nand sebaceous gland disorder.\n","PeriodicalId":11004,"journal":{"name":"Current Drug Therapy","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2024-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Drug Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115748855297829240227072642","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

It was asserted that the manufacturing of liposomes, which was first disclosed in 1961, was a useful technology for drug encapsulation. Furthermore, there are several cosmetic items on the market now that include liposomes. The liposomes are novel drug carrier systems due to their similarity in lipid composition with the epidermal membrane. As a result, they penetrate the epidermis to a greater extent, showing enhanced skin absorption and increased effectiveness of the encapsulated drug molecule. This review briefly addresses the skin's anatomy, skin conditions, and the topical delivery of drugs for the treatment of skin diseases with emphasis on psoriasis by utilizing liposomes and other vesicular drug delivery systems along with challenges and opportunities in the treatment of skin diseases. When compared to alternative distribution methods, their resemblance to biological membranes enables entry into the epidermal barrier. Liposomes are good at penetrating the skin more deeply and reducing therapeutic side effects, which offers hope for the successful treatment of skin problems. Applying liposomes topically has several benefits, including better skin bioavailability and targeting, increased skin hydration by surface adhesiveness, protection of skin structure from external stress, and prolonged dermal release. Further, they have got potential to target the encapsulated drug molecule into pilosebaceous structure, making them an ideal candidate for the treatment of hair follicles and sebaceous gland disorder.
脂质体是治疗皮肤病的潜在药物输送系统:综述
据说,脂质体的制造技术于 1961 年首次公开,是一种有用的药物封装技术。此外,目前市场上有几种化妆品含有脂质体。脂质体是一种新型的药物载体系统,因为其脂质成分与表皮膜相似。本综述简要论述了皮肤解剖、皮肤状况、局部给药治疗皮肤病,重点是利用脂质体和其他囊状给药系统治疗银屑病,以及治疗皮肤病的挑战和机遇。脂质体能更深入地渗透皮肤并减少治疗副作用,这为成功治疗皮肤问题带来了希望。局部应用脂质体有多种好处,包括更好的皮肤生物利用度和靶向性、通过表面粘附性增加皮肤水合作用、保护皮肤结构免受外部压力影响以及延长皮肤释放时间。此外,脂质体还具有将包裹的药物分子靶向进入皮脂腺结构的潜力,因此是治疗毛囊和皮脂腺疾病的理想选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Drug Therapy
Current Drug Therapy PHARMACOLOGY & PHARMACY-
CiteScore
1.30
自引率
0.00%
发文量
50
期刊介绍: Current Drug Therapy publishes frontier reviews of high quality on all the latest advances in drug therapy covering: new and existing drugs, therapies and medical devices. The journal is essential reading for all researchers and clinicians involved in drug therapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信